New! View global litigation for patent families

WO2006119598A3 - Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor - Google Patents

Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor

Info

Publication number
WO2006119598A3
WO2006119598A3 PCT/BR2006/000090 BR2006000090W WO2006119598A3 WO 2006119598 A3 WO2006119598 A3 WO 2006119598A3 BR 2006000090 W BR2006000090 W BR 2006000090W WO 2006119598 A3 WO2006119598 A3 WO 2006119598A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
device
skin
way
slow
surface
Prior art date
Application number
PCT/BR2006/000090
Other languages
French (fr)
Other versions
WO2006119598A2 (en )
Inventor
Jean Marc Millet
Original Assignee
Jean Marc Millet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Abstract

Device for slow liberation via transdermal process of a medicine for reducing an excess of cholesterol and method of production of a transdermic device, which is characterized by a bi-laminate device comprising a flexible macromolecular matrix (2) providing a thickness from 0,15 to 0,6 cm and a surface from 10 to 100 square cm and a posterior coating (1) on one side which allows a considerable reduction (more than 15 times) of the doses to be administered in the treatment of an excess of cholesterol; the macromolecular matrix contains and liberates in a continuous way for a period between 1 to 4 months from 0,05 to 0,18% per day of its total weight of Omega-3 follyocid and / or statin by its surface in contact with the patient's skin without being necessarily the device to be adhered in a fix and permanent way to his / her skin.
PCT/BR2006/000090 2005-05-10 2006-05-10 Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor WO2006119598A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0501708-4 2005-05-10
BRPI0501708 2005-05-10

Publications (2)

Publication Number Publication Date
WO2006119598A2 true WO2006119598A2 (en) 2006-11-16
WO2006119598A3 true true WO2006119598A3 (en) 2007-03-01

Family

ID=37396906

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2006/000090 WO2006119598A3 (en) 2005-05-10 2006-05-10 Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor

Country Status (1)

Country Link
WO (1) WO2006119598A3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940116B1 (en) * 2008-12-22 2012-07-06 Philippe Perovitch Formulation for administration of lipid-lowering oral transmucosal route
US9107983B2 (en) 2010-10-27 2015-08-18 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising statins
US8877221B2 (en) 2010-10-27 2014-11-04 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
US9308190B2 (en) 2011-06-06 2016-04-12 Warsaw Orthopedic, Inc. Methods and compositions to enhance bone growth comprising a statin

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3325130A1 (en) * 1983-06-29 1985-01-03 Dick P R Pharmaceutical composition for application to the skin on the basis of essential fatty acids and containing the same device
EP0965340A1 (en) * 1996-12-23 1999-12-22 Nippon Suisan Kaisha, Ltd. Dermatologic preparation
WO2002038196A2 (en) * 2000-11-11 2002-05-16 Beiersdorf Ag Plaster with skincare substances

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3325130A1 (en) * 1983-06-29 1985-01-03 Dick P R Pharmaceutical composition for application to the skin on the basis of essential fatty acids and containing the same device
EP0965340A1 (en) * 1996-12-23 1999-12-22 Nippon Suisan Kaisha, Ltd. Dermatologic preparation
WO2002038196A2 (en) * 2000-11-11 2002-05-16 Beiersdorf Ag Plaster with skincare substances

Also Published As

Publication number Publication date Type
WO2006119598A2 (en) 2006-11-16 application

Similar Documents

Publication Publication Date Title
Singh et al. Autophagy in the cellular energetic balance
WO2002036592A1 (en) Remedies for arachidonic acid-induced skin diseases
WO2004006906A3 (en) Methods for the treatment of neoplasms
Gwaltney 2nd Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase IV.
WO2007142295A1 (en) Novel tape preparation
Anschel et al. Focally injected adenosine prevents seizures in the rat
WO2008093670A1 (en) Fermentation product of grape skin/seed by lactic acid bacteria, and pharmaceutical agent and food utilizing the same
Jones et al. Capsaicin 8% topical patch (Qutenza)—a review of the evidence
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
WO2007094497A1 (en) Ameliorating agent for metabolic syndrome
US20070248696A1 (en) Composition and method for enhancing neuromuscular facilitation and cognitive functions
WO2008086794A3 (en) Medical product for treating stenosis of body passages and for preventing threatening restenosis
WO2005027842A3 (en) Combinations of drugs for the treatment of neoplasms
Murrell Oxygen free radicals and tendon healing
WO2006025247A1 (en) Mitochondria activators
Att et al. N-Acetyl cysteine prevents suppression of oral fibroblast function on poly (methylmethacrylate) resin
WO2005087286A1 (en) Biological tissue sheet, method of forming the same and transplantation method by using the sheet
WO2002048136A1 (en) Keratinocyte proliferation inhibitors
WO2005078087A1 (en) Antibody targeting osteoclast-associated protein
WO2005087206A3 (en) Cancer therapy comprising a nuclear receptor ligand and a hdac inhibitor
US20130296324A1 (en) Novel compositions comprising a phosphodiesterase-5 inhibitor and their use in methods of treatment
WO2002098440A1 (en) Drugs for diabetes
WO2005014042A1 (en) HEART-SLOWING DRUG CONTAINING SHORT-ACTING β BLOCKER AS THE ACTIVE INGREDIENT
WO2006085521A1 (en) Medicinal composition for transdermal absorption containing opipid receptor antagonist, method of producing the same and method of promoting the transdermal absorption of the antagonist
WO2008155999A1 (en) Gabaergic neuron activator

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase in:

Ref country code: DE

NENP Non-entry into the national phase in:

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06721647

Country of ref document: EP

Kind code of ref document: A2